Kellner Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Kellner Capital’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-75,800	Closed	-$1.83M	–	40
2023 Q1	$1.83M	Buy	+75,800	New	+$951K	2.55%	14

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Kellner Capital's PRVB Position: Q2 2023 in Review

Kellner Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 75,800 shares — an estimated $1.83M sold.

Kellner Capital first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $1.83M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Kellner Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Kellner Capital sold 75,800 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.83M.
Kellner Capital first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Kellner Capital's Provention Bio, Inc. Common Stock position peaked at $1.83M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Kellner Capital's 13F filing for Q2 2023, filed 11 Aug 2023.